GBIO
Price
$0.50
Change
-$0.03 (-5.66%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
33.44M
51 days until earnings call
ORMP
Price
$2.52
Change
-$0.05 (-1.95%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
101.59M
78 days until earnings call
Ad is loading...

GBIO vs ORMP

Header iconGBIO vs ORMP Comparison
Open Charts GBIO vs ORMPBanner chart's image
Generation Bio
Price$0.50
Change-$0.03 (-5.66%)
Volume$2.25K
Capitalization33.44M
Oramed Pharmaceuticals
Price$2.52
Change-$0.05 (-1.95%)
Volume$2.6K
Capitalization101.59M
GBIO vs ORMP Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. ORMP commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Buy and ORMP is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (GBIO: $0.53 vs. ORMP: $2.14)
Brand notoriety: GBIO and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 74% vs. ORMP: 120%
Market capitalization -- GBIO: $33.44M vs. ORMP: $101.59M
GBIO [@Biotechnology] is valued at $33.44M. ORMP’s [@Biotechnology] market capitalization is $101.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • GBIO’s TA Score: 5 bullish, 2 bearish.
  • ORMP’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than ORMP.

Price Growth

GBIO (@Biotechnology) experienced а -10.29% price change this week, while ORMP (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

GBIO is expected to report earnings on May 01, 2025.

ORMP is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($102M) has a higher market cap than GBIO($33.4M). ORMP YTD gains are higher at: -11.570 vs. GBIO (-50.236). ORMP has higher annual earnings (EBITDA): 9.44M vs. GBIO (-92.57M). GBIO has more cash in the bank: 185M vs. ORMP (142M). ORMP has less debt than GBIO: ORMP (429K) vs GBIO (93.8M). GBIO has higher revenues than ORMP: GBIO (18.6M) vs ORMP (0).
GBIOORMPGBIO / ORMP
Capitalization33.4M102M33%
EBITDA-92.57M9.44M-981%
Gain YTD-50.236-11.570434%
P/E RatioN/A22.91-
Revenue18.6M0-
Total Cash185M142M130%
Total Debt93.8M429K21,865%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
52
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOORMP
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 7 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 7 days ago
84%
MACD
ODDS (%)
Bullish Trend 7 days ago
85%
Bearish Trend 7 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
83%
Advances
ODDS (%)
Bullish Trend about 1 month ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
87%
Bearish Trend 7 days ago
84%
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
83%
View a ticker or compare two or three
Ad is loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-1.79%
ABOS - GBIO
48%
Loosely correlated
+5.22%
ATNM - GBIO
47%
Loosely correlated
+3.77%
AURA - GBIO
45%
Loosely correlated
+4.02%
NAUT - GBIO
43%
Loosely correlated
-2.42%
MGTX - GBIO
42%
Loosely correlated
+3.01%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with XERS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+7.00%
XERS - ORMP
37%
Loosely correlated
+1.63%
AKBA - ORMP
31%
Poorly correlated
N/A
FULC - ORMP
28%
Poorly correlated
+0.93%
APLS - ORMP
27%
Poorly correlated
+4.11%
PRLD - ORMP
27%
Poorly correlated
+8.19%
More